Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05705440
What this trial is testing

A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 3,855
Early research (Phase 1)Study completedNCT02478333
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Pharmaceutical K.K. 24
Not applicableStudy completedNCT02016690
What this trial is testing

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie 312
Not applicableStudy completedNCT00369759
What this trial is testing

An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants

Who this might be right for
Respiratory InfectionsBronchiolitisPneumonia+1 more
MedImmune LLC 2,048
Large-scale testing (Phase 3)Study completedNCT07117487
What this trial is testing

MRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 507
Not applicableStudy completedNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,792
Not applicableUnknownNCT06175611
What this trial is testing

Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection

Who this might be right for
SARS-CoV2 InfectionInfluenza AInfluenza B+1 more
EDAN Instruments Inc. 1,000
Early research (Phase 1)Study completedNCT01805921
What this trial is testing

RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.

Who this might be right for
Respiratory Syncytial Virus Infections
ReiThera Srl 72
Testing effectiveness (Phase 2)Study completedNCT02135614
What this trial is testing

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infection
Gilead Sciences 189
Early research (Phase 1)Study completedNCT04444284
What this trial is testing

Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children

Who this might be right for
Respiratory Syncytial Virus Infections
Meissa Vaccines, Inc. 34
Early research (Phase 1)Active Not RecruitingNCT06904222
What this trial is testing

Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection
Guangzhou Patronus Biotech Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT02878330
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 1,453
Not applicableEnded earlyNCT05105191
What this trial is testing

Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room

Who this might be right for
Influenza Viral InfectionsRSV Infection
Erasme University Hospital 280
Early research (Phase 1)Study completedNCT04227210
What this trial is testing

Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Meissa Vaccines, Inc. 20
Large-scale testing (Phase 3)Study completedNCT03979313
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)

Who this might be right for
Respiratory Syncytial Virus Infections
AstraZeneca 3,012
Not applicableStudy completedNCT05964582
What this trial is testing

Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

Who this might be right for
Respiratory Syncytial Virus Infections
Sanofi Pasteur, a Sanofi Company 344
Not applicableStudy completedNCT00593918
What this trial is testing

Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children

Who this might be right for
Respiratory Syncytial Virus Infection
University of Wisconsin, Madison 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT07092865
What this trial is testing

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 168
Early research (Phase 1)Study completedNCT01852266
What this trial is testing

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT02297594
What this trial is testing

Safety, Tolerability and PK Study of AK0529 in Healthy Human

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 74
Next Page